Under the Sunshine Act, every payment a manufacturer makes to a clinician is public record. These pages roll it up for you: one manufacturer, one state, one year at a time, with the payment mix and the products behind it. No clinician is named here; the ranked, named lists live in Prospect 811.
The major device makers so far. More land as we expand; tell us who you sell against at [email protected].
$119.2M general payments (excl. buyouts) · 51,076 clinicians · 2025 · 50 state pages
Medtronic$107.0M general payments (excl. buyouts) · 77,681 clinicians · 2025 · 51 state pages
Johnson & Johnson$188.3M general payments (excl. buyouts) · 211,139 clinicians · 2025 · 51 state pages
Zimmer Biomet$50.0M general payments (excl. buyouts) · 9,735 clinicians · 2025 · 46 state pages
Boston Scientific$53.9M general payments (excl. buyouts) · 79,424 clinicians · 2025 · 50 state pages
Smith+Nephew$48.1M general payments (excl. buyouts) · 25,188 clinicians · 2025 · 49 state pages
Globus Medical$35.8M general payments (excl. buyouts) · 14,214 clinicians · 2025 · 46 state pages
Abbott$36.2M general payments (excl. buyouts) · 71,890 clinicians · 2025 · 50 state pages
Arthrex$105.5M general payments (excl. buyouts) · 5,513 clinicians · 2025 · 38 state pages
Intuitive Surgical$57.5M general payments (excl. buyouts) · 15,541 clinicians · 2025 · 49 state pages
Edwards Lifesciences$15.2M general payments (excl. buyouts) · 18,103 clinicians · 2025 · 48 state pages
Enovis$27.8M general payments (excl. buyouts) · 2,959 clinicians · 2025 · 28 state pages
Prospect 811 covers every reporting manufacturer, every state, 2019 through 2025, down to the named clinician, cross-linked to Medicare billing. $79/month, no contract, 14-day refund.
Start prospecting →